CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389,927 | -30.3% | 17,862 | +1.5% | 0.00% | -40.0% |
| Q2 2023 | $559,536 | +26.6% | 17,601 | -2.9% | 0.01% | +25.0% |
| Q1 2023 | $441,898 | -20.3% | 18,118 | +3.1% | 0.00% | -20.0% |
| Q4 2022 | $554,442 | +21.6% | 17,579 | +9.1% | 0.01% | 0.0% |
| Q3 2022 | $456,000 | +8.1% | 16,119 | +1.0% | 0.01% | +25.0% |
| Q2 2022 | $422,000 | +1.0% | 15,960 | +33.7% | 0.00% | +33.3% |
| Q1 2022 | $418,000 | +10.3% | 11,940 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $379,000 | +11.1% | 11,697 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $341,000 | +53.6% | 11,560 | +33.7% | 0.00% | +50.0% |
| Q2 2021 | $222,000 | – | 8,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |